Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Niloff

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Obstetrics & Gynecology|February 1, 1991
Ovarian malignancyJ M Niloff
Oncology (Williston Park, N.Y.)|August 1, 1988
The role of the CA 125 assay in the management of ovarian cancerJ M Niloff
American Journal of Obstetrics and Gynecology|August 1, 1982
Metabolism of 3H-dopamine by human chorioamnion in vitroM Phillippe, J M Niloff
The Journal of Reproductive Medicine|June 9, 1999
Outpatient minilaparotomy for ovarian cystsM K Flynn, J M Niloff
Obstetrics and Gynecology|August 1, 1993
Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapyY B Kim, J M Niloff
Gynecologic Oncology|September 30, 1999
Early discharge after abdominal surgery: experience on a gynecologic oncology serviceC R Rardin, C J Weisman, Y B Kim, et al.
Cancer|February 15, 1987
Late recurrence in endometrial carcinomaG S Lederman, J M Niloff, R Redline, et al.
Lasers in Surgery and Medicine|September 13, 2001
Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopyR J Nordstrom, L Burke, J M Niloff, et al.
American Journal of Obstetrics and Gynecology|April 1, 1985
Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerJ M Niloff, R C Bast, E M Schaetzl, et al.
Obstetrics and Gynecology|November 1, 1984
CA125 antigen levels in obstetric and gynecologic patientsJ M Niloff, R C Knapp, E Schaetzl, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Obstetrics & Gynecology|February 1, 1991
Ovarian malignancyJ M Niloff
Oncology (Williston Park, N.Y.)|August 1, 1988
The role of the CA 125 assay in the management of ovarian cancerJ M Niloff
American Journal of Obstetrics and Gynecology|August 1, 1982
Metabolism of 3H-dopamine by human chorioamnion in vitroM Phillippe, J M Niloff
The Journal of Reproductive Medicine|June 9, 1999
Outpatient minilaparotomy for ovarian cystsM K Flynn, J M Niloff
Obstetrics and Gynecology|August 1, 1993
Endometrial carcinoma: analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapyY B Kim, J M Niloff
Gynecologic Oncology|September 30, 1999
Early discharge after abdominal surgery: experience on a gynecologic oncology serviceC R Rardin, C J Weisman, Y B Kim, et al.
Cancer|February 15, 1987
Late recurrence in endometrial carcinomaG S Lederman, J M Niloff, R Redline, et al.
Lasers in Surgery and Medicine|September 13, 2001
Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopyR J Nordstrom, L Burke, J M Niloff, et al.
American Journal of Obstetrics and Gynecology|April 1, 1985
Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancerJ M Niloff, R C Bast, E M Schaetzl, et al.
Obstetrics and Gynecology|November 1, 1984
CA125 antigen levels in obstetric and gynecologic patientsJ M Niloff, R C Knapp, E Schaetzl, et al.
Pageof 3